These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16596576)

  • 1. A dose-response test via closed-form solutions for constrained MLEs in survival/sacrifice experiments.
    Kim W; Ahn H; Moon H
    Stat Med; 2007 Feb; 26(3):694-708. PubMed ID: 16596576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of k for the poly-k test with application to animal carcinogenicity studies.
    Moon H; Ahn H; Kodell RL; Lee JJ
    Stat Med; 2003 Aug; 22(16):2619-36. PubMed ID: 12898548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Order-restricted dose-related trend tests.
    Mancuso JY; Ahn H; Chen JJ
    Stat Med; 2001 Aug; 20(15):2305-18. PubMed ID: 11468765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An age-adjusted bootstrap-based Poly-k test.
    Moon H; Ahn H; Kodell RL
    Stat Med; 2005 Apr; 24(8):1233-44. PubMed ID: 15573413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of false positive rates of peto and poly-3 methods for long-term carcinogenicity data analysis using multiple comparison adjustment method suggested by Lin and Rahman.
    Rahman MA; Lin KK
    J Biopharm Stat; 2008; 18(5):949-58. PubMed ID: 18781527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity.
    Bieler GS; Williams RL
    Biometrics; 1993 Sep; 49(3):793-801. PubMed ID: 8241374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global tests for analysis of multiple tumour data from animal carcinogenicity experiments.
    Chen JJ
    Stat Med; 1996 Jun; 15(11):1217-25. PubMed ID: 8804149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly-k-trend tests for survival adjusted analysis of tumor rates formulated as approximate multiple contrast test.
    Schaarschmidt F; Sill M; Hothorn LA
    J Biopharm Stat; 2008; 18(5):934-48. PubMed ID: 18781526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of lag time between onset of and death from an occult tumor.
    Ahn H; Moon H; Kodell RL
    J Biopharm Stat; 2008; 18(5):901-14. PubMed ID: 18781524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of historical controls in time-adjusted trend tests for carcinogenicity.
    Ibrahim JG; Ryan LM
    Biometrics; 1996 Dec; 52(4):1478-85. PubMed ID: 8962464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constant risk differences in the analysis of animal tumorigenicity data.
    Dinse GE
    Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using historical controls in the analysis of developmental toxicity data.
    Ryan L
    Biometrics; 1993 Dec; 49(4):1126-35. PubMed ID: 8117906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioassay design and MTD setting: old methods and new approaches.
    Swenberg JA
    Regul Toxicol Pharmacol; 1995 Feb; 21(1):44-51; discussion 81-6. PubMed ID: 7784635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonparametric estimation of the distribution of time to onset for specific diseases in survival/sacrifice experiments.
    Turnbull BW; Mitchell TJ
    Biometrics; 1984 Mar; 40(1):41-50. PubMed ID: 6733233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consonant closed likelihood ratio test procedures with application to dose-response study.
    Wang B; Cui X
    Stat Med; 2010 Nov; 29(25):2617-30. PubMed ID: 20740552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An age-adjusted trend test for the tumor incidence rate for multiple-sacrifice experiments.
    Kodell RL; Ahn H
    Biometrics; 1997 Dec; 53(4):1467-74. PubMed ID: 9423261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confidence intervals for the 50 per cent response dose.
    Faraggi D; Izikson P; Reiser B
    Stat Med; 2003 Jun; 22(12):1977-88. PubMed ID: 12802816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.
    Dinse GE; Lagakos SW
    Biometrics; 1982 Dec; 38(4):921-32. PubMed ID: 7168795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.